A novel protein-DNA interaction involved with the CpG dinucleotide at -30 upstream is linked to the DNA methylation mediated transcription silencing of the MAGE-A1 gene

Cell Research

Volumn 14, Issue 4, 2004, Pages 283-294

  Zhang, Jie ^a   Yu, Jian ^a   Gu, Jun ^a   Gao, Bao Mei ^a   Zhao, Ying Jun ^a   Wang, Peng ^a   Zhang, Hong Yu ^a   Zhu, Jing De ^a  

^a SHANGHAI JIAO TONG UNIVERSITY   (China)

Author keywords

DNA methylation; MAGE A1; Transcriptional regulation

Indexed keywords

DNA; HISTONE; MELANOMA SPECIFIC ANTIGENS; MELANOMA-SPECIFIC ANTIGENS; TUMOR PROTEIN;

ARTICLE; CPG ISLAND; DNA METHYLATION; GENE EXPRESSION PROFILING; GENE SILENCING; GENETICS; HUMAN; LIVER CELL CARCINOMA; LIVER TUMOR; METABOLISM; NUCLEOTIDE SEQUENCE; PHYSIOLOGY; PROMOTER REGION; SILENCER ELEMENT; TUMOR CELL LINE;

BASE SEQUENCE; CARCINOMA, HEPATOCELLULAR; CELL LINE, TUMOR; CPG ISLANDS; DNA; DNA METHYLATION; GENE EXPRESSION PROFILING; GENE SILENCING; HISTONES; HUMANS; LIVER NEOPLASMS; NEOPLASM PROTEINS; PROMOTER REGIONS (GENETICS); SILENCER ELEMENTS, TRANSCRIPTIONAL;

EID: 16644377530     PISSN: 10010602     EISSN: 17487838     Source Type: Journal    
DOI: 10.1038/sj.cr.7290229     Document Type: Article

References (21)

1. Jaenisch R, Bird A. Epigenetic regulation of gene expression: how the genome integrates intrinsic and environmental signals. Nat Gene 2003; 33 Suppl:245-54.
2. Baylin S, Bestor TH. Altered methylation patterns in cancer cell genomes: cause or consequence? Cancer Cell 2002; 1(4):299-305.
3. Neibergs HL, Hein DW, Spratt JS. Genetic profiling of colon cancer. J Surg Qncol 2002; 80(4):204-13.
4. Yu J, Zhang HY, Ma ZZ, et al. Methylation profiling of twenty four genes and the concordant methylation behaviours of nineteen genes that may contribute to hepatocellular carcinogenesis. Cell Res 2003; 13(5):319-33.
5. Mou DC, Cai SL, Peng JR, et al. Evaluation of MAGE-1 and MAGE-3 as tumour-specific markers to detect blood dissemination of hepatocellular carcinoma cells. Br J Cancer 2002; 86(1):110-6.
6. van der Bruggen P, Traversari C, Chomez P, et al. A gene encoding an antigen recognized by cytolytic T lymphocytes on a human melanoma. Science 1991; 254(5038):1643-7.
7. Barker PA, Salehi A. The MAGE proteins: emerging roles in cell cycle progression, apoptosis, and neurogenetic disease. J Neurosci Res 2002; 67(6):705-12.
8. Serrano A, Garcia A, Abril E, et al. Methylated CpG points identified within MAGE-1 promoter are involved in gene repression. Int J Cancer 1996; 68(4):464-70.
9. De Smet C, Courtois SJ, Faraoni I, et al. Involvement of two Ets binding sites in the transcriptional activation of the MAGE1 gene. Immunogenetics 1995; 42(4):282-90.
10. De Smet C, De Backer O, Faraoni I, et al. The activation of human gene MAGE-1 in tumor cells is correlated with genomewide demethylation. Proc Natl Acad Sci USA 1996; 93(14):7149-53.
11. De Smet C, Lurquin C, Lethe B, et al. DNA methylation is the primary silencing mechanism for a set of germ line- and tumor-specific genes with a CpG-rich promoter. Mol Cell Biol 1999; 19(11):7327-35.
12. Xu J, De Zhu J, Ni M, et al. The ATF/CREB site is the key element for transcription of the human RNA methyltransferase like 1(RNMTL1) gene, a newly discovered 17p13.3 gene. Cell Res 2002; 12(3-4):177-97.
13. Guo JY, Xu J, Mao Q, et al. The promoter analysis of the human C17orf25 gene, a novel chromosome 17p13.3 gene. Cell Res 2002; 12(5-6):339-52.
14. Cai L, Zhu JD. The tumor-selective over-expression of the human Hsp70 gene is attributed to the aberrant controls at both initiation and elongation levels of transcription. Cell Res 2003; 13(2):93-109.
15. Yu J, Ni M, Xu J, et al. Methylation profiling of twenty promoter-CpG islands of genes which may contribute to hepatocellular carcinogenesis. BMC Cancer 2002; 2(1):29.
16. Zhu JD. The myeloid-lineage specific enhancer of the mouse myeloperoxidase gene consists of three cis-elements defined as in vitro DNase I footprints. FEBS Lett 1994; 339(3):243-8.
17. Fisher RJ, Mavrothalassitis G, Kondoh A, Papas TS. High-affinity DNA-protein interactions of the cellular ETS1 protein: the determination of the ETS binding motif. Oncogene 1991; 6(12):2249-54.
18. Garcia J, Wu F, Gaynor R. Upstream regulatory regions required to stabilize binding to the TATA sequence in an adenovirus early promoter. Nucleic Acids Res 1987; 15(20):8367-85.
19. Richter JD. In vivo photocrosslinking reveals that transcription factor binding to the mammalian ATF recognition sequence is required for E1A-induced transactivation in injected Xenopus laevis oocytes. Nucleic Acids Res 1989; 17(12):4503-16.
20. Strahl K. The JUN oncoprotein, a vertebrate transcription factor, activates transcription in yeast. Nature 1988; 332(6165):649-50.
21. Mertin S, McDowall SG, Harley VR. The DNA-binding specificity of SOX9 and other SOX proteins. Nucleic Acids Res 1999; 27(5):1359-64.